Clear all search history
Law & Crime
Disasters & Accidents
War & Conflict
Hospitality & Recreation
Nexavar articles over last 30 days
articles last 30 days
articles per day
Mentioned in this news
Generic drug makers get a boost from SC ruling
... sales of the low cost version of its kidney cancer drug, sorafenib tosylate (branded as
), by Natco Pharmaceuticals. Hyderabad-based Natco was granted the first and to date only...
Read more at The Hindu
Bombay High Court
India rejects German plea on cancer drug
... Indian generics group, Natco Pharma, to produce a cheaper version of Bayer's cancer drug,
, in India. Following the grant, Bayer has been fighting the permit, which allows the Indian...
Read more at
+ 3 more articles
National IPR policy relook: Government moves slow...
... to Natco Pharma to produce and sell generic versions of Bayer-Onyx's cancer drug,
. Things became worse last year in April when the Supreme Court rejected a patent application...
Read more at Business Standard India
World Trade Organization
Latest from Twitter
Parts of this website powered by Open Calais, a toolkit for rich semantic metadata extraction.
Interceder is a topic search engine aggregating the latest news on any topic into a single window of information. This page has been automatically generated. To contact Interceder
Your privacy is important. Interceder does not collect and keep any personal information about visitors to the site. Interceder may use third-party advertising companies to serve ads. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements on this website, other websites, and other forms of media about goods and services of interest to you.